Cumberland Partners LTD Abbott Laboratories Transaction History

Cumberland Partners LTD

$1.33 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $120,331 - $134,074	-1,194 Reduced 1.73%	67,920 $7.4 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $10.3 Million - $12.2 Million	-106,657 Reduced 60.68%	69,114 $7 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $150,860 - $176,982	-1,587 Reduced 0.89%	175,771 $19.3 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.12 Million - $1.29 Million	-11,528 Reduced 6.1%	177,358 $17.2 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $62,568 - $75,625	613 Added 0.33%	188,886 $20.5 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $992,544 - $1.21 Million	8,705 Added 4.85%	188,273 $22.3 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $424,688 - $520,006	3,676 Added 2.09%	179,568 $25.3 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $819,069 - $906,130	-7,021 Reduced 3.84%	175,892 $20.8 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $818,920 - $963,986	-7,741 Reduced 4.06%	182,913 $21.2 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $734,016 - $864,783	6,744 Added 3.67%	190,654 $22.8 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $357,630 - $389,714	3,406 Added 1.89%	183,910 $20.1 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $275,836 - $334,982	-3,010 Reduced 1.64%	180,504 $19.6 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $74,119 - $94,864	-968 Reduced 0.52%	183,514 $16.8 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $11.3 Million - $16.6 Million	180,332 Added 4345.35%	184,482 $14.6 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $51,031 - $56,810	-650 Reduced 13.54%	4,150 $360,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $24,552 - $26,622	300 Added 6.67%	4,800 $402,000
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $65,592 - $76,500	900 Added 25.0%	4,500 $378,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $236,016 - $267,372	3,600 New	3,600 $260,000

Others Institutions Holding ABT

# of Institutions

3,336

Shares Held

1.36B

Call Options Held

10M

Put Options Held

9.48M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$22 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$17.1 Billion
0.31% of portfolio
State Street Corp Boston, MA

77.2M
Shares

$10.1 Billion
0.35% of portfolio
Capital International Investors Los Angeles, CA

68M
Shares

$8.88 Billion
1.51% of portfolio
Capital Research Global Investors Los Angeles, CA

54.1M
Shares

$7.07 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.

Account